Back to Barclays plc Barclays plc

CORTCORT

Showing 9 of 32 quarters

Position history for Barclays plcBarclays plc's holdings in Corcept Therapeutics Incorporated

Yes. Barclays holds 375,738 shares of CORT (Corcept Therapeutics), worth $43.3M, as of its Q3 2026 13F filing. It increased the position by 238,705 shares (+174.2%) from Q2 2026. Barclays has held CORT in every 13F on record since Q4 2018, 32 quarterly filings.

Current Value

$43.3M

Current Shares

375,738

Total Value Change

+$28.2M

Total Shares Change

+49,785

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
375,738
+174.2%
$43.3M0.0%$115.23
47
2026-Q2
Decreased
137,033
-20.4%
$11.9M0.0%$86.95
0
2026-Q1
Increased
172,078
+452.2%
$6.9M0.0%$40.31
44
2025-Q4
Increased
31,163
+140.1%
$1.1M0.0%$34.80
41
2025-Q3
Decreased
12,981
-78.1%
$1.1M0.0%$83.11
0
2025-Q2
Decreased
59,362
-53.1%
$4.4M0.0%$73.40
0
2025-Q1
Decreased
126,451
-25.0%
$14.4M0.0%$114.22
0
2024-Q4
Decreased
168,527
-48.3%
$8.5M0.0%$50.39
0
2024-Q3
Increased
325,953
+23.3%
$15.1M0.0%$46.28
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used